EN | UA
EN | UA

Help Support

Back

Understanding the clinical, radiological and laboratory outcomes associated with COVID-19 neurology

Understanding the clinical, radiological and laboratory outcomes associated with COVID-19 neurology Understanding the clinical, radiological and laboratory outcomes associated with COVID-19 neurology
Understanding the clinical, radiological and laboratory outcomes associated with COVID-19 neurology Understanding the clinical, radiological and laboratory outcomes associated with COVID-19 neurology

To completely understand the emerging spectrum of neurological ailments in COVID-19 patients via a weekly virtual COVID-19 neurology multi-disciplinary conference.

See All

Key take away

Keeping in view the detailed description of neurological disorders in 43 patients wit COVID-19, this retrospective review found whole neuraxis (plus cerebral vasculature) to be affected by COVID. Also, none of the autoantibodies observed in acute disseminated encephalomyelitis were linked with this infectious disease.

Background

To completely understand the emerging spectrum of neurological ailments in COVID-19 patients via a weekly virtual COVID-19 neurology multi-disciplinary conference.

Method

In early March 2020, this conference was held to discuss and begin to apprehend neurological presentations in COVID-19 patients assumed to have neurological ailments. Detailed clinical and paraclinical data were gathered from patients where the diagnosis of COVID-19 was confirmed through RNA Polymerase chain reaction (PCR), or where the diagnosis was probable and possible as per the WHO standards.

Result

Twenty nine patients were COVID-19 PCR positive and definite, 8 probable and 6 possible, out of the total 43 patients included. The main groups emerged has been displayed in the following table:

Conclusion

The whole neuraxis (cerebral vasculature and response to immunotherapies in few patients) is affected due to the presence of SARS-CoV-2 infection. Of particular interest is the incidence of acute disseminated encephalomyelitis, mainly with the haemorrhagic change, not linked to COVID-19 severity. Future clinical, neuroradiological, biomarker and neuropathological studies are important to understand the causal pathobiological mechanisms for better management of this infection. 

Source:

BRAIN- A Journal of Neurology

Article:

The emerging spectrum of COVID-19 neurology: clinical, radiological and laboratory findings

Authors:

Ross W Paterson et al.

Comments (0)

You want to delete this comment? Please mention comment Invalid Text Content Text Content cannot me more than 1000 Something Went Wrong Cancel Confirm Confirm Delete Hide Replies View Replies View Replies en ru ua
Try: